blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3802495

EP3802495 - HETEROCYCLIC DERIVATIVES AND USE THEREOF [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  28.04.2023
Database last updated on 11.09.2024
FormerRequest for examination was made
Status updated on  12.03.2021
FormerThe international publication has been made
Status updated on  07.12.2019
Most recent event   Tooltip28.05.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
C&C Research Laboratories
Sungkyunkwan University
2066 Seobu-ro
Jangan-gu
Suwon-si
Gyeonggi-do 16419 / KR
[2021/15]
Inventor(s)01 / PARK, Chan Hee
C&C Research Labs., DRC, Sungkyunkwan University
2066, Seobu-ro, Jangan-gu
Suwon-si Gyeonggi-do 16419 / KR
02 / IM, Jun Hwan
C&C Research Labs., DRC, Sungkyunkwan University
2066, Seobu-ro, Jangan-gu
Suwon-si Gyeonggi-do 16419 / KR
03 / LEE, Soon Ok
C&C Research Labs., DRC, Sungkyunkwan University
2066, Seobu-ro, Jangan-gu
Suwon-si Gyeonggi-do 16419 / KR
04 / LEE, Sang Hwi
C&C Research Labs., DRC, Sungkyunkwan University
2066, Seobu-ro, Jangan-gu
Suwon-si Gyeonggi-do 16419 / KR
05 / KO, Kwang Seok
C&C Research Labs., DRC, Sungkyunkwan University
2066, Seobu-ro, Jangan-gu
Suwon-si Gyeonggi-do 16419 / KR
06 / KIM, Byung Ho
C&C Research Labs., DRC, Sungkyunkwan University
2066, Seobu-ro, Jangan-gu
Suwon-si Gyeonggi-do 16419 / KR
07 / MOON, Hyung Jo
C&C Research Labs., DRC, Sungkyunkwan University
2066, Seobu-ro, Jangan-gu
Suwon-si Gyeonggi-do 16419 / KR
08 / KIM, Jae Ill
C&C Research Labs., DRC, Sungkyunkwan University
2066, Seobu-ro, Jangan-gu
Suwon-si Gyeonggi-do 16419 / KR
09 / PARK, Heon Kyu
C&C Research Labs., DRC, Sungkyunkwan University
2066, Seobu-ro, Jangan-gu
Suwon-si Gyeonggi-do 16419 / KR
10 / HONG, Yeon Ju
C&C Research Labs., DRC, Sungkyunkwan University
2066, Seobu-ro, Jangan-gu
Suwon-si Gyeonggi-do 16419 / KR
 [2021/15]
Representative(s)Wohlfahrt, Jan Günther, et al
Gleiss Große Schrell und Partner mbB
Patentanwälte Rechtsanwälte
Leitzstraße 45
70469 Stuttgart / DE
[2021/15]
Application number, filing date19812552.831.05.2019
[2021/15]
WO2019KR06554
Priority number, dateKR2018006245031.05.2018         Original published format: KR 20180062450
[2021/15]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019231271
Date:05.12.2019
Language:EN
[2019/49]
Type: A1 Application with search report 
No.:EP3802495
Date:14.04.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 05.12.2019 takes the place of the publication of the European patent application.
[2021/15]
Search report(s)International search report - published on:KR05.12.2019
(Supplementary) European search report - dispatched on:EP14.03.2022
ClassificationIPC:C07D215/38, C07D215/48, C07D215/50, C07D239/94, C07D471/04, C07D487/04, C07D491/048, C07D495/04, C07D513/04, A61K31/47, A61K31/502, A61K31/517, A61K31/53, A61P31/06, A61P35/00, A61P37/00
[2022/15]
CPC:
A61P31/06 (EP,KR); C07D215/38 (EP,KR,US); C07D239/72 (US);
A61K31/47 (KR); A61K31/502 (KR); A61K31/517 (KR);
A61K31/53 (KR); A61P35/00 (EP,KR); A61P37/00 (EP,KR);
C07D215/48 (EP,US); C07D215/50 (EP); C07D239/94 (EP);
C07D471/04 (EP); C07D473/34 (US); C07D487/04 (EP);
C07D491/048 (EP); C07D495/04 (EP); C07D513/04 (EP) (-)
Former IPC [2021/15]C07D215/38, A61K31/47, A61K31/502, A61K31/517, A61K31/53, A61P35/00, A61P37/00, A61P31/06
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/15]
TitleGerman:HETEROCYCLISCHE DERIVATE UND VERWENDUNG DAVON[2021/15]
English:HETEROCYCLIC DERIVATIVES AND USE THEREOF[2021/15]
French:DÉRIVÉS HÉTÉROCYCLIQUES ET LEUR UTILISATION[2021/15]
Entry into regional phase11.01.2021National basic fee paid 
11.01.2021Search fee paid 
11.01.2021Designation fee(s) paid 
11.01.2021Examination fee paid 
Examination procedure11.01.2021Examination requested  [2021/15]
17.08.2022Amendment by applicant (claims and/or description)
03.05.2023Despatch of a communication from the examining division (Time limit: M04)
29.08.2023Reply to a communication from the examining division
14.12.2023Despatch of a communication from the examining division (Time limit: M04)
04.04.2024Reply to a communication from the examining division
Fees paidRenewal fee
31.05.2021Renewal fee patent year 03
16.03.2022Renewal fee patent year 04
31.05.2023Renewal fee patent year 05
27.05.2024Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO2008086462  (WYETH CORP [US], et al) [X] 1-13 * page 38; intermediates of formula (VI) * * example 264; page 123, paragraph [00382] to paragraph [00384]; (2N-dimethylamino-7-methyl-quinazolin-4-yl)-(4-nitro-benzyl)-amine; (4-Amino-benzyl)-(2-methylamino-7-methyl-quinazolin- 4-yl)-amine; (2N-methylamino-8-methyl-quinazolin-4-yl)-(4-nitro-benzyl)-amine; (2-Chloro-8-methyl-quinazolin-4-yl)-(4-nitro-benzyl)-amine; (2N-dimethylamino-8-methyl-quinazolin-4-yl)-(4-nitro- benzyl)-amine; (4-Amino-benzyl)-(2-methylamino-8-methyl-quinazolin-4-yl)-amine (2N-methylamino-7-methyl-quinazolin-4-yl)-(4-nitro-benzyl)-amine *;
 [X]WO2010036629  (NAT HEALTH RESEARCH INSTITUTES, et al) [X] 1-13 * page 36; lines 10 to 12; example 2; intermediate in the preparation of compound 6; N-[2-(4-aminophenyl)ethyl]-7-(3-chloropropoxy)-4-quinazolinamine (STN-RN: 1220105-88-3) *;
 [XI]WO2010093419  (MERCK PATENT GMBH [DE], et al) [X] 1-13 * page 42; table; compound 151 * * claims 1, 10 * [I] 1-13;
 [XI]WO2012079079  (HARVARD COLLEGE [US], et al) [X] 1-13 * figure 15; figure page 33/46; compound C72; N-[(4-aminophenyl)methyl]-6-chloro-4-quinazolinamine (STN-RN: 1262888-97-0); intermediate in the preparation of compound C72; 6-chloro-N-[(4-nitrophenyl)methyl]-4-quinazolinamine; STN-RN: 1262888-82-3 * * claims 1, 125 * [I] 1-13;
 [XPI]WO2019046778  (MAVUPHARMA INC [US]) [XP] 1-13 * page 9; 3rd, 7th and 9th compound * * page 99 - page 114; compounds 230, 247, 293, 306, 406 * * claims 97, 123-144 *[I] 1-13
International search[X]WO2005061516  (SMITHKLINE BEECHAM CORP [US], et al) [X] 1-13 * See claims 1-4; page 24; example 11. *;
 [X]WO2009007422  (BAYER SCHERING PHARMA AG [DE], et al) [X] 1-13 * See claims 1, 4-18; compound 20. *;
 [A]US2010234324  (EGGENWEILER HANS-MICHAEL [DE], et al) [A] 1-13 * See the whole document. *;
 [A]US2011172429  (ASAI AKIRA [JP], et al) [A] 1-13* See the whole document. *;
 [X]WO2014145512  (HARVARD COLLEGE [US], et al) [X] 1-13 * See abstract; claims 1-3, 8; pages 5-7, 19; figure 1. *
by applicantWO2005061516
 WO2008086462
 WO2009007422
 WO2010036629
 WO2010093419
 US2010234324
 US2011172429
 WO2012079079
 WO2014145512
 WO2019046778
    - BECKER S et al., Nature, (19980000), page 394
    - VINKEMEIER U et al., Science, (19980000), page 279
    - CHEN X et al., Cell, (19980000), page 93
    - D. NECULAI et al., J. Biol. Chem., (20050000), page 280
    - SCHINDLER C et al., Annu. Rev. Biochem., (19950000), page 64
    - NOVICK D et al., Cell, (19940000), page 76
    - HO AS et al., Proc. Natl. Acad. Sci., (19930000), page 90
    - STARK et al., Annu. Rev. Biochem., (19970000), page 67
    - LEVY et al., Nat. Rev. Mol. Cell Biol., (20020000), page 3
    - ZHONG et al., Science, (19940000), page 264
    - MASUDA et al., Cancer Res., (20020000), page 62
    - BENEKLI et al., Blood, (20020000), page 99
    - YUICHI et al., Int. J. Oncology, (20070000), page 30
    - AKIRA et al., Oncogene, (20000000), page 19
    - SIDDIQUEE et al., Proc. Natl. Acad. Sci., (20070000), page 104
    - SIDDIQUEE et al., Chem. Biol., (20070000), page 2
    - LIN et al., Neoplasia, (20100000), page 12
    - SCHUST et al., Chem. Biol., (20060000), page 13
    - SONG et al., Proc. Natl. Acad. Sci., (20050000), page 102
    - ZHANG et al., Biochem. Pharm., (20100000), page 79
    - MATSUNO et al., ACS Med. Chem. Lett., (20100000), page 1
    - TURKSON J et al., Mol Cancer Ther., (20040000), page 261
    - COLEMAN et al., J. Med. Chem., (20050000), page 48
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.